Loading…

OA06.03 Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2021-03, Vol.16 (3), p.S112-S113
Main Authors: Majem, M., Goldman, J., John, T., Grohe, C., Laktionov, K.K., Kim, S., Kato, T., Vu, H.V., Lu, S., Lee, K.Y., Akewanlop, C., Yu, C., De Marinis, F., Bonanno, L., Domine, M., Shepherd, F., Zeng, L., Kulkarni, D., Medic, N., Tsuboi, M., Herbst, R., Wu, Y.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2021.01.291